|

Role of Gut Microbiome in Cancer Therapy

RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2019-09-11
Est. completion2029-10-01
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT05112614

Summary

This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18-99
* Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancer therapy or undergoing stem cell transplant for any hematological condition

Exclusion Criteria:

* Unable to provide informed consent
* Vulnerable adults

Conditions3

CancerHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Locations3 sites

Arizona

1 site
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259

Florida

1 site
Mayo Clinic in Florida
Jacksonville, Florida, 32224

Minnesota

1 site
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Clinical Trials Referral Office855-776-0015mayocliniccancerstudies@mayo.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.